Arcturus Therapeutics Europe B.V.
- Address
- Claude Debussylaan 10
Sponsor Overview
Specializations
Respiratory Disease and Pulmonary Medicine
Arcturus Therapeutics Europe B.V. is active in clinical research focused on cystic fibrosis, with attention to the treatment of chronic respiratory impairment and the underlying disease burden affecting the lungs and airways.
- Cystic Fibrosis
- Chronic Lung Disease
- Airway Function
The sponsor’s research activity is centered on improving clinical outcomes in a condition marked by persistent pulmonary complications and progressive respiratory involvement.
Genetic and Rare Disease Research
The company’s trial portfolio includes work in genetic disorders, with a specific therapeutic interest in the inherited mechanisms that drive cystic fibrosis and its multisystem effects.
- Inherited Disease
- Rare Disease Therapeutics
- CFTR-related Pathology
This area reflects a focus on conditions where targeted clinical development is directed toward disease-specific biological dysfunction.
Clinical Safety and Tolerability
Research activity includes evaluation of safety and tolerability in people living with cystic fibrosis, with clinical interest in how investigational therapy is received in the target population.
- Safety Evaluation
- Tolerability Assessment
- Patient Response
The sponsor’s clinical focus in this area is aligned with advancing therapies for a population with significant ongoing treatment needs.
Therapeutic Innovation in CF Treatment
Arcturus Therapeutics Europe B.V. is involved in research on investigational approaches for cystic fibrosis, with interest in treatment strategies intended to address disease manifestations across the respiratory system.
- Investigational Therapy
- Respiratory Treatment Development
- Disease-Targeted Care
Its clinical work is concentrated on a single active area of therapeutic development for a serious chronic condition.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 2 Open-Label Study Evaluating Safety, Tolerability, and Efficacy of ARCT-032 (mRNA Encoding Human CFTR Gene) in Cystic Fibrosis Patients |  Greece Poland | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 4 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
4 centres- Address
- Exochi, 570 10 Thessaloniki
- Address
- Konstadinoupoleos 49, 546 42 Thessaloniki
- Address
- Ul. Plocka 26, 01-138 Warsaw
- Address
- ul. Wladyslawa Warnenczyka 111, 35-612 Rzeszów
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Arcturus Therapeutics Europe B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.